Nomura Asset Management International’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Nomura Asset Management International's JAZZ Position: Q2 2026 in Review
Nomura Asset Management International held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 31,300 shares worth $7.54M. The position accounts for 0.01% of the portfolio, ranked #810.
Nomura Asset Management International first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Nomura Asset Management International held 31,300 shares of Jazz Pharmaceuticals worth $7.54M as of Q2 2026.
- Nomura Asset Management International left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
- Jazz Pharmaceuticals made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #810 holding.
- Nomura Asset Management International first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.